{"disease":{"id":"leishmaniasis-cutaneous","name":"leishmaniasis cutaneous"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06917040","title":"Enhancing Protection Against Vector-borne Diseases in Forcibly Displaced Communities: Evaluating the Efficacy of Spatial Repellents for Cutaneous Leishmaniasis Control in North-East Syria","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":18404,"lead_sponsor_name":"The Mentor Initiative","has_results":false},{"nct_id":"NCT07504757","title":"LEISH-PED: Study on Leishmaniasis in Children","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Meyer Children's Hospital IRCCS","has_results":false},{"nct_id":"NCT05708625","title":"Intralesional Voriconazole, or Intralesional Cryotherapy, or Oral Doxycycline in the Treatment of Cutaneous Leishmaniasis","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":136,"lead_sponsor_name":"Zagazig University","has_results":false},{"nct_id":"NCT03969134","title":"A Study to Assess the Safety, Efficacy and Immunogenicity of Leishmania Vaccine ChAd63-KH in PKDL","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":86,"lead_sponsor_name":"University of York","has_results":false},{"nct_id":"NCT03096457","title":"Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Fundacion Nacional de Dermatologia","has_results":false},{"nct_id":"NCT04841239","title":"Development of Topical Herbal Formulations for Treatment of Cutaneous Leishmaniasis","phase":"NA","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"Jinnah Sindh Medical University","has_results":false},{"nct_id":"NCT03929016","title":"Single Oral Dose Escalation Study of DNDI-0690 in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"Drugs for Neglected Diseases","has_results":false},{"nct_id":"NCT03445897","title":"Miltefosine Plus IL Pentamidine for Bolivian CL","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Jonathan Berman","has_results":false},{"nct_id":"NCT04888130","title":"Investigation of an Outbreak Situation of Cutaneous Leishmaniasis Among Military Personnel in French Guiana (CEFELEISH)","phase":"","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Centre Hospitalier de Cayenne","has_results":false},{"nct_id":"NCT03303898","title":"ASYMPTOMATIC CARRIER OF LEISHMANIA INFANTUM, MEDISERRANEAN VISCERAL LEISHMANIOSIS AGENT: STUDY OF IMMUNE RESPONSE -","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nice","has_results":false},{"nct_id":"NCT07149753","title":"Pilot Study: Miltefosine Gel (G-MTF) in Patients With Cutaneous Leishmaniasis","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":15,"lead_sponsor_name":"Universidad Industrial de Santander","has_results":false},{"nct_id":"NCT03999970","title":"A Clinical Study to Develop an Uninfected Sand Fly Biting Protocol","phase":"NA","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"University of York","has_results":false},{"nct_id":"NCT04512742","title":"A Clinical Study to Develop a Controlled Human Infection Model Using Leishmania Major-infected Sand Flies","phase":"NA","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"University of York","has_results":false},{"nct_id":"NCT01641796","title":"Paromomycin for Individuals With Uncomplicated Cutaneous Leishmaniasis","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"U.S. Army Medical Research and Development Command","has_results":false},{"nct_id":"NCT00508963","title":"Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"University of California, San Francisco","has_results":false}],"total":15},"guidelines":[],"source":"Drug Landscape verified database"}